The European Commission has launched a public call for expressions of interest to appoint six independent scientific experts to the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency. Those experts are appointed as members of the PRAC for a period of three years, which may be prolonged once and thereafter renewed. This call is intended to select candidates to replace the current independent experts as of July 2, 2018.
The call, application, and declaration of interests form can be found on the European Commission website. The deadline for submission of applications is September 30, 2017.
Applications should be delivered either by email at SANTE-CONSULT-A3@ec.europa.eu or by post at European Commission, Health and Food Safety Directorate-General, Unit A3 Finance, Budget and Controls, Call for Interest (PRAC/17/EXP), 1049 Brussels, Belgium.
For any further inquiry on this call, please contact the European Commission directly at SANTE-CONSULTA3@ec.europa.eu y referring in the subject of the email to “Call PRAC/17/EXP.”